While not the known target of any commonly used antimalarials, Top1 mutations could provide resistance to fluoroquinolone antibiotics such as ciprofloxacin which targets the bacterial topoisomerase, gyrase B, and is commonly taken by patients with HIV infection. The gene discussed is TOP1; the disease is HIV infectious disease.